Results: 54

El uso de toxina botulínica en el tratamiento de la neuralgia del trigémino (V par craneal)

Odovtos (En línea); 20 (3), 2018
ABSTRACT The Trigeminal Neuralgia (TN) is described as neuropathic pain at the orofacial level, characterized by unbearable pain that can last from a few seconds to several minutes. The different treatments used for these patients are to numb the nerve, surgical, pharmacological, and the administration a...

Tratamento de disfunções temporomandibulares com toxina botulínica tipo A

RFO UPF; 23 (2), 2018
Introdução: a disfunção temporomandibular (DTM) abrange muitos problemas clínicos nas articulações, na musculatura e em outras regiões da oroface. A origem multifatorial e sua etiologia envolvem fatores psicocomportamentais, oclusais e neuromusculares, seu diagnóstico é realizado pela anamnese ...

Botulinum toxin A (BT-A) versus low-level laser therapy (LLLT) in chronic migraine treatment: a comparison

Arq. neuropsiquiatr; 76 (10), 2018
ABSTRACT The aim of this work was to evaluate patients with chronic migraine treated with botulinum toxin A (BT-A) and compare this with low level laser therapy (LLLT), referencing: pain days, pain intensity, intake of drugs/self-medication, anxiety and sleep disorders. Methods: Patients were randomized...

Blepharospasm with elevated anti-acetylcholine receptor antibody titer

Arq. neuropsiquiatr; 76 (8), 2018
ABSTRACT Objective: To determine whether serum levels of anti-acetylcholine receptor antibody (anti-AChR-Abs) are related to clinical parameters of blepharospasm (BSP). Methods: Eighty-three adults with BSP, 60 outpatients with hemifacial spasm (HFS) and 58 controls were recruited. Personal history, de...

Toxina Botulínica para el Tratamiento de los Desórdenes Temporomandibulares

RESUMEN: Los Trastornos Temporomandibulares (TTM) consisten en un conjunto de condiciones patológicas que afectan la articulación temporomandibular (ATM), los músculos de la masticación y las estructuras asociadas. Estudios epidemiológicos estiman que 40 % a 75 % de la población adulta presenta por...

Botulinum toxin for hereditary spastic paraplegia: effects on motor and non-motor manifestations

Arq. neuropsiquiatr; 76 (3), 2018
ABSTRACT Motor and non-motor manifestations are common and disabling features of hereditary spastic paraplegia (HSP). Botulinum toxin type A (Btx-A) is considered effective for spasticity and may improve gait in these patients. Little is known about the effects of Btx-A on non-motor symptoms in HSP patie...

Onabotulinumtoxin type A improves lower urinary tract symptoms and quality of life in patients with human T cell lymphotropic virus type 1 associated overactive bladder

Braz. j. infect. dis; 22 (2), 2018
ABSTRACT Aim: To evaluate the efficacy of the onabotulinum toxin type A in the treatment of HTLV-1 associated overactive bladder and its impact on quality of life (QoL). Methods: Case series with 10 patients with overactive bladder refractory to conservative treatment with anticholinergic or physical t...

Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors

Clinics; 73 (), 2018
OBJECTIVES: Vocal tremors, which cause social difficulties for patients, may be classified as resting or action tremors. Of the vocal action tremors, essential and dystonic tremors are the most common. Botulinum toxin and oral medications have been used to treat vocal tremors, but no comparative clinical...

Lysozyme gene treatment in testosterone induced benign prostate hyperplasia rat model and comparasion of its' effectiveness with botulinum toxin injection

Int. braz. j. urol; 43 (6), 2017
ABSTRACT Objectives: To compare the effects and histopathological changes of botulinum neurotoxin type A and lysozyme gene injections into prostate tissue within a testosterone induced benign prostate hyperplasia rat model. Materials and Methods: 40 male Wistar rats were randomized into four Groups. Gr...